tradingkey.logo

Prophase Labs Inc

PRPH
0.615USD
-0.072-10.48%
收盘 12/24, 13:00美东报价延迟15分钟
2.55M总市值
亏损市盈率 TTM

Prophase Labs Inc

0.615
-0.072-10.48%

关于 Prophase Labs Inc 公司

ProPhase Labs, Inc. is a biotech, genomics, and consumer products company. The Company is engaged in providing whole genome sequencing solutions, diagnostic development, such as its potentially life-saving test for the early detection of esophageal cancer and a direct-to-consumer marketing platform for OTC dietary supplements. It develops, manufactures, and commercializes health and wellness solutions. Its Diagnostic services segment provides diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. Its Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and provides personal genomics products and services. The Company also develops and markets dietary supplements under the TK Supplement brand, which includes Legendz XL and Triple Edge XL.

Prophase Labs Inc简介

公司代码PRPH
公司名称Prophase Labs Inc
上市日期Jan 16, 1984
CEOKarkus (Ted William)
员工数量96
证券类型Ordinary Share
年结日Jan 16
公司地址711 Stewart Ave, Suite 200
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编11530
电话12153450919
网址https://www.prophaselabs.com/
公司代码PRPH
上市日期Jan 16, 1984
CEOKarkus (Ted William)

Prophase Labs Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.22M
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
103.84K
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Ted William Karkus
Mr. Ted William Karkus
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
3.22M
--
Dr. Louis Gleckel, M.D.
Dr. Louis Gleckel, M.D.
Independent Director
Independent Director
103.84K
--
Ms. Carolina Abenante, Esq.
Ms. Carolina Abenante, Esq.
Independent Director
Independent Director
--
--
Mr. Steven M. Plumb, CPA
Mr. Steven M. Plumb, CPA
Fractional Chief Financial Officer
Fractional Chief Financial Officer
--
--
Mr. Warren Hirsch, CPA
Mr. Warren Hirsch, CPA
Independent Director
Independent Director
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Karkus (Ted William)
5.57%
Sykon Capital LLC
1.12%
The Vanguard Group, Inc.
0.92%
Susquehanna International Group, LLP
0.69%
Geode Capital Management, L.L.C.
0.53%
其他
91.17%
持股股东
持股股东
占比
Karkus (Ted William)
5.57%
Sykon Capital LLC
1.12%
The Vanguard Group, Inc.
0.92%
Susquehanna International Group, LLP
0.69%
Geode Capital Management, L.L.C.
0.53%
其他
91.17%
股东类型
持股股东
占比
Individual Investor
5.75%
Investment Advisor
4.32%
Investment Advisor/Hedge Fund
0.70%
Hedge Fund
0.10%
Research Firm
0.08%
Venture Capital
0.05%
其他
88.99%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
86
3.04M
7.33%
-2.51M
2025Q2
91
7.80M
18.77%
+525.30K
2025Q1
95
8.38M
29.57%
+1.62M
2024Q4
97
6.02M
20.15%
-197.61K
2024Q3
101
5.16M
20.53%
-1.27M
2024Q2
102
5.11M
20.47%
-1.25M
2024Q1
100
5.62M
31.27%
-1.27M
2023Q4
102
5.60M
32.69%
-985.39K
2023Q3
105
5.94M
34.65%
-718.97K
2023Q2
102
6.16M
36.72%
-636.57K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Karkus (Ted William)
3.22M
7.74%
--
--
Apr 29, 2025
Sykon Capital LLC
644.79K
1.55%
+644.79K
--
Jun 30, 2025
The Vanguard Group, Inc.
408.27K
0.98%
--
--
Jun 30, 2025
Susquehanna International Group, LLP
102.02K
0.25%
+28.00K
+37.84%
Jun 30, 2025
Geode Capital Management, L.L.C.
259.06K
0.62%
+31.37K
+13.78%
Jun 30, 2025
Gleckel (Louis)
103.84K
0.25%
--
--
Apr 29, 2025
Chapin Davis Asset Management
80.00K
0.19%
--
--
Jun 30, 2025
Swisspartners Investment Network AG
50.00K
0.12%
+50.00K
--
Jun 30, 2024
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Dimensional US Core Equity 1 ETF
0%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
Dimensional US Core Equity 1 ETF
占比0%
Avantis US Equity ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%
iShares Micro-Cap ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Dec 12, 2025
Merger
10→1
公告日期
类型
比率
Dec 12, 2025
Merger
10→1

常见问题

Prophase Labs Inc的前五大股东是谁?

Prophase Labs Inc 的前五大股东如下:
Karkus (Ted William)持有股份:3.22M,占总股份比例:7.74%。
Sykon Capital LLC持有股份:644.79K,占总股份比例:1.55%。
The Vanguard Group, Inc.持有股份:408.27K,占总股份比例:0.98%。
Susquehanna International Group, LLP持有股份:102.02K,占总股份比例:0.25%。
Geode Capital Management, L.L.C.持有股份:259.06K,占总股份比例:0.62%。

Prophase Labs Inc的前三大股东类型是什么?

Prophase Labs Inc 的前三大股东类型分别是:
Karkus (Ted William)
Sykon Capital LLC
The Vanguard Group, Inc.

有多少机构持有Prophase Labs Inc(PRPH)的股份?

截至2025Q3,共有86家机构持有Prophase Labs Inc的股份,合计持有的股份价值约为3.04M,占公司总股份的7.33%。与2025Q2相比,机构持股有所增加,增幅为-11.44%。

哪个业务部门对Prophase Labs Inc的收入贡献最大?

在--,--业务部门对Prophase Labs Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI